.. .. Analyse-mutationnelle,

R. .. ,

. .. Discussion, 55 5-Implication de l'activation constante de MAPKinase dans l'Histiocytose langerhansienne pulmonaire

C. .. ,

B. 1. Janeway, C. A. Murphy, K. , T. P. Walport, and M. Immunobiologie, , 2009.

M. Merad, F. Ginhoux, and C. M. , Origin, homeostasis and function of Langerhans cells and other langerin-expressing dendritic cells, Nat Rev Immunol, vol.8, issue.12, pp.935-947, 2008.

J. Emile, O. Abla, and S. Fraitag, Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages, Blood, vol.127, issue.22, pp.2672-2681, 2016.

R. Haupt, M. Minkov, and I. Astigarraga, Langerhans Cell Histiocytosis (LCH): Guidelines for Diagnosis, Clinical Work-Up, and Treatment for Patients Till the Age, vol.18

. Years, Pediatr Blood Cancer, 5. Langerhans Cell Histiocytosis (LCH)-Children, vol.60, pp.175-184, 2013.

, Langerhans Cell Histiocytosis (LCH)-Adults

F. Ginhoux, F. Tacke, and V. Angeli, Langerhans cells arise from monocytes in vivo

, Nat Immunol, vol.7, issue.3, pp.265-273, 2006.

H. S. Suri, E. S. Yi, G. S. Nowakowski, and R. Vassallo, Pulmonary langerhans cell histiocytosis, Orphanet J Rare Dis, vol.7, p.16, 2012.

M. Collin, V. Bigley, K. L. Mcclain, C. Allen, C. L. Willman et al., Langerhans'-Cell Histiocytosis (Histiocytosis X)-A Clonal Proliferative Disease, Hematol Oncol Clin North Am, vol.29, issue.5, pp.154-160, 1994.

C. E. Allen, L. Li, and T. L. Peters, Cell-Specific Gene Expression in Langerhans Cell Histiocytosis Lesions Reveals a Distinct Profile Compared to Epidermal Langerhans Cells, J Immunol Baltim Md, vol.184, issue.8, pp.4557-4567, 1950.

C. Hutter, M. Kauer, and I. Simonitsch-klupp, Notch is active in Langerhans cell histiocytosis and confers pathognomonic features on dendritic cells, Blood, vol.120, issue.26, pp.5199-5208, 2012.

, Langerhans' cell histiocytosis: expression of leukocyte cellular adhesion molecules suggests abnormal homing and differentiation, 2018.

J. D. Laman, P. Leenen, N. E. Annels, P. Hogendoorn, and R. M. Egeler, Langerhans-cell histiocytosis "insight into DC biology, Trends Immunol, vol.24, issue.4, pp.190-196, 2003.

C. Dorard, G. Vucak, and M. Baccarini, Deciphering the RAS/ERK pathway in vivo

G. , V. Macconaill, and L. E. , Recurrent NRAS mutations in pulmonary Langerhans cell histiocytosis, Biochem Soc Trans, vol.45, issue.1, pp.1919-1923, 2010.

F. Sahm, D. Capper, and M. Preusser, BRAFV600E mutant protein is expressed in cells of variable maturation in Langerhans cell histiocytosis, Blood, vol.120, issue.12, pp.28-34, 2012.

G. Badalian-very, J. Vergilio, B. A. Degar, C. Rodriguez-galindo, and B. J. Rollins, Recent advances in the understanding of Langerhans cell histiocytosis, Hematol Oncol Clin North Am, vol.156, issue.2, pp.839-851, 2012.

R. Chakraborty, O. A. Hampton, and X. Shen, Mutually exclusive recurrent somatic mutations in MAP2K1 and BRAF support a central role for ERK activation in LCH pathogenesis, Somatic activating ARAF mutations in Langerhans cell histiocytosis | Blood Journal, vol.124, pp.3007-3015, 2014.

N. A. Accessed-;-brown, L. V. Furtado, and B. L. Betz, High prevalence of somatic MAP2K1 mutations in BRAF V600E-negative Langerhans cell histiocytosis, Blood, vol.124, issue.10, pp.1655-1658, 2014.

M. Berres, K. Lim, and T. Peters, BRAF-V600E expression in precursor versus differentiated dendritic cells defines clinically distinct LCH risk groups, J Exp Med, vol.212, issue.2, p.281, 2015.

O. Abla and S. Weitzman, Treatment of Langerhans cell histiocytosis: role of BRAF/MAPK inhibition. ASH Educ Program Book, vol.2015, pp.565-570, 2015.

R. J. Arceci, Biological and therapeutic implications of the BRAF pathway in histiocytic disorders, Am Soc Clin Oncol Educ Book Am Soc Clin Oncol Meet, vol.2014, pp.441-445

S. Héritier, M. Jehanne, and G. Leverger, Multisystemic and Multiresistant Langerhans Cell Histiocytosis: A Case Treated With BRAF Inhibitor, J Natl Compr Cancer Netw JNCCN, vol.1, issue.6, pp.715-718, 2015.

, Meeting Library | Biological and Therapeutic Implications of the BRAF Pathway in Histiocytic Disorders, 2018.

A. Tazi, J. Moreau, A. Bergeron, S. Dominique, A. J. Hance et al., Evidence That Langerhans Cells in Adult Pulmonary Langerhans Cell Histiocytosis Are Mature Dendritic Cells: Importance of the Cytokine Microenvironment, J Immunol, vol.163, issue.6, pp.3511-3515, 1999.

R. Vassallo, J. H. Ryu, D. R. Schroeder, P. A. Decker, and A. H. Limper, Clinical Outcomes of Pulmonary Langerhans'-Cell Histiocytosis in Adults, N Engl J Med, vol.346, issue.7, pp.484-490, 2002.

S. Asilsoy, N. Yazici, S. Demir, A. Erbay, E. Koçer et al., A different cause for respiratory disorder in children: cases with pulmonary Langerhans cell histiocytosis, Clin Respir J, vol.11, issue.2, pp.193-199, 2017.

P. Presse-medicale, S. A. Fr-;-yousem, T. V. Colby, Y. Y. Chen, W. G. Chen et al., Pulmonary Langerhans' cell histiocytosis: molecular analysis of clonality, Am J Surg Pathol, vol.39, issue.1, pp.630-636, 1983.

A. Tazi, L. Montcelly, A. Bergeron, D. Valeyre, J. P. Battesti et al., Relapsing nodular lesions in the course of adult pulmonary Langerhans cell histiocytosis, Am J Respir Crit Care Med, vol.157, issue.6, pp.2007-2010, 1998.

G. Lorillon, V. Meignin, and A. Tazi,

P. Presse-medicale, A. Fr-;-tazi, C. De-margerie, and J. M. Naccache, The natural history of adult pulmonary Langerhans cell histiocytosis: a prospective multicentre study, Orphanet J Rare Dis, vol.46, issue.1, pp.70-78, 1983.

P. Wei, H. Lu, S. Jiang, L. Fan, H. Li et al., Pulmonary Langerhans Cell Histiocytosis: Case Series and Literature Review, Am J Respir Crit Care Med, vol.153, issue.23, pp.426-435, 1996.

N. Mogulkoc, A. Veral, P. W. Bishop, U. Bayindir, C. A. Pickering et al., Pulmonary Langerhans' cell histiocytosis: radiologic resolution following smoking cessation, Chest, vol.115, issue.5, pp.1452-1455, 1999.

J. L. Mendez, H. F. Nadrous, R. Vassallo, P. A. Decker, and J. H. Ryu, Pneumothorax in pulmonary Langerhans cell histiocytosis, Chest, vol.125, issue.3, pp.1028-1032, 2004.

A. Tazi, C. De-margerie-mellon, and L. Vercellino, Extrathoracic investigation in adult patients with isolated pulmonary langerhans cell histiocytosis, Orphanet J Rare Dis, vol.11, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01269910

A. Tazi, K. Marc, and S. Dominique, Serial computed tomography and lung function testing in pulmonary Langerhans' cell histiocytosis, Eur Respir J, vol.40, issue.4, pp.905-912, 2012.

J. Lacronique, C. Roth, J. P. Battesti, F. Basset, and J. Chretien, Chest radiological features of pulmonary histiocytosis X: a report based on 50 adult cases, Thorax, vol.37, issue.2, pp.104-109, 1982.

H. E. Westerlaan and P. Van-der-valk, Clinical and radiological evolution in patients with pulmonary Langerhans' cell histiocytosis, Neth J Med, vol.60, issue.8, pp.320-326, 2002.

P. Soler, A. Bergeron, and M. Kambouchner, Is High-Resolution Computed Tomography a Reliable Tool to Predict the Histopathological Activity of Pulmonary Langerhans Cell Histiocytosis?, Am J Respir Crit Care Med, vol.162, issue.1, pp.264-270, 2000.

M. Abbritti, M. A. Mazzei, and E. Bargagli, Utility of spiral CAT scan in the follow-up of patients with pulmonary Langerhans cell histiocytosis, Eur J Radiol, vol.81, issue.8, pp.1907-1912, 2012.

M. Baqir, R. Vassallo, F. Maldonado, E. S. Yi, and J. H. Ryu, Utility of bronchoscopy in pulmonary Langerhans cell histiocytosis, J Bronchol Interv Pulmonol, vol.20, issue.4, pp.309-312, 2013.

S. Harari, O. Torre, R. Cassandro, A. M. Taveira-dasilva, and J. Moss, Bronchoscopic Diagnosis of Langerhans Cell Histiocytosis and Lymphangioleiomyomatosis, Respir Med, vol.106, issue.9, pp.1286-1292, 2012.

G. Dauriat, H. Mal, and G. Thabut, Echocardiographic and Clinical Characteristics of Pulmonary Hypertension Complicating Pulmonary Langerhans Cell Histiocytosis, Transplantation, vol.81, issue.5, pp.1269-1275, 2004.

L. Pavec, J. Lorillon, G. Jaïs, and X. , Pulmonary Langerhans Cell HistiocytosisAssociated Pulmonary Hypertension: Clinical Characteristics and Impact of Pulmonary Arterial Hypertension Therapies, Chest, vol.142, issue.5, pp.1150-1157, 2012.

N. Gupta, R. Vassallo, K. A. Wikenheiser-brokamp, and F. X. Mccormack, Diffuse Cystic Lung Disease. Part I, Am J Respir Crit Care Med, vol.191, issue.12, pp.1354-1366, 2015.

N. Gupta, R. Vassallo, K. A. Wikenheiser-brokamp, and F. X. Mccormack, Diffuse Cystic Lung Disease. Part II, Am J Respir Crit Care Med, vol.192, issue.1, pp.17-29, 2015.

B. J. Krajicek, J. H. Ryu, T. E. Hartman, V. J. Lowe, and R. Vassallo, Abnormal Fluorodeoxyglucose PET in Pulmonary Langerhans Cell Histiocytosis, Chest, vol.135, issue.6, pp.1542-1549, 2009.

G. Lorillon and A. Tazi, How I manage pulmonary Langerhans cell histiocytosis, Eur Respir Rev, vol.26, issue.145, p.170070, 2017.
DOI : 10.1183/16000617.0070-2017

URL : http://err.ersjournals.com/content/errev/26/145/170070.full.pdf

G. Lorillon, A. Bergeron, and L. Detourmignies, Cladribine Is Effective against Cystic Pulmonary Langerhans Cell Histiocytosis, Am J Respir Crit Care Med, vol.186, issue.9, pp.930-932, 2012.
DOI : 10.1164/ajrccm.186.9.930

URL : https://hal.archives-ouvertes.fr/hal-00873182

V. Grobost, C. Khouatra, R. Lazor, J. Cordier, and V. Cottin, Progressive diffuse pulmonary Langerhans cell histiocytosis improved by cladribine chemotherapy | Thorax, Orphanet J Rare Dis, vol.9, 2014.

A. Delobbe, J. Durieu, A. Duhamel, and B. Wallaert, Groupe d'Etude en Pathologie Interstitielle de la Societe de Pathologie Thoracique du Nord, Eur Respir J, vol.9, issue.10, pp.2002-2006, 1996.

E. Brabencova, A. Tazi, and M. Lorenzato, Langerhans cells in Langerhans cell granulomatosis are not actively proliferating cells, Am J Pathol, vol.152, issue.5, pp.1143-1149, 1998.

B. Senechal, G. Elain, and E. Jeziorski, Expansion of Regulatory T Cells in Patients with Langerhans Cell Histiocytosis, PLoS Med, vol.4, issue.8, 2007.
URL : https://hal.archives-ouvertes.fr/inserm-00702777

J. Marchal, M. Kambouchner, A. Tazi, D. Valeyre, P. Soler et al., Immunohistochemical study of matrix metalloproteinases and their tissue inhibitors in pulmonary Langerhans' cell granulomatosis, Arch Pathol Lab Med, vol.45, issue.1, pp.930-937, 1997.

A. Prasse, M. Stahl, and G. Schulz, Pulmonary Langerhans Cell Histiocytosis: Profiling of Multifocal Tumors Using Next-Generation Sequencing Identifies Concordant Occurrence of BRAF V600E Mutations, Am J Pathol, vol.174, issue.5, pp.1679-1684, 2009.

A. C. Roden, X. Hu, and S. Kip, BRAF V600E expression in Langerhans cell histiocytosis: clinical and immunohistochemical study on 25 pulmonary and 54 extrapulmonary cases, Am J Surg Pathol, vol.38, issue.4, pp.548-551, 2014.

C. Pierry, C. Caumont, and E. Blanchard, Assessment of Arch, pp.1-12, 2017.

M. Berres, M. Merad, and C. E. Allen, Progress in understanding the pathogenesis of Langerhans cell histiocytosis: back to Histiocytosis X?, Br J Haematol, vol.169, issue.1, pp.3-13, 2015.